A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2019; you can also visit the original URL.
The file type is application/pdf.
Losers of Primary Cilia Gain the Benefit of Survival
2017
Cancer Discovery
Preserved Fulltext
In this issue, Zhao and colleagues demonstrate that loss of primary cilia in medulloblastoma cells confers resistance to the Smoothened (SMO) inhibitor sonidegib. When treated with sonidegib, medulloblastoma cells lost their cilia and gained resistance. Surprisingly, loss of cilia is associated with recurrent mutations in ciliogenesis genes that are eventually able to drive drug resistance. These fi ndings uncover a previously unknown mechanism of cancer cells in gaining a "persister-like"
doi:10.1158/2159-8290.cd-17-1085
pmid:29208776
fatcat:7wjjztduwjgi3mj33s6fj7qiwi